Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand
文献类型:期刊论文
作者 | Shi M(施敏) ; Zhang W(张雯) |
刊名 | Adv. Synth. Catal.
![]() |
出版日期 | 2005 |
卷号 | 347期号:4页码:535-540 |
其他题名 | 磺酰胺和膦酰胺类手性配体和铜盐催化的金属锌试剂和环状不饱和酮的加成反应 |
通讯作者 | 施敏 |
英文摘要 | The chiral sulfonamide-thiophosphoramide ligand L1, prepared from the reaction of (1R,2R)(-)-1,2-cyclohexanediamine with diphenylthiophosphoryl chloride and p-toluenesulfonyl chloride, was used as a chiral ligand in Cu(MeCN)(4)ClO4-promoted catalytic asymmetric addition of diethylzinc to cyclic enones using LiCl as an additive in which up to 90% ee can be realized under mild conditions within 0.5 h. This chiral ligand is stable and recoverable after usual work-up and can be reused in the same catalytic asymmetric reaction. Moreover, it was found that this series of chiral ligands represents a type of S,O-bidentate ligands on the basis of H-1 NMR, P-31 NMR and 13 C NMR spectroscopic investigations. The linear effect of ligand ee and product ee further revealed that the active species is a monomeric Cu(I) complex bearing a single ligand. |
学科主题 | 金属有机化学 |
收录类别 | SCI |
原文出处 | http://dx.doi.org/10.1002/adsc.200404321 |
语种 | 英语 |
公开日期 | 2013-01-09 |
源URL | [http://202.127.28.38/handle/331003/10004] ![]() |
专题 | 上海有机化学研究所_金属有机化学国家重点实验室 |
推荐引用方式 GB/T 7714 | Shi M,Zhang W. Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand[J]. Adv. Synth. Catal.,2005,347(4):535-540. |
APA | Shi M,&Zhang W.(2005).Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand.Adv. Synth. Catal.,347(4),535-540. |
MLA | Shi M,et al."Asymmetric 1,4-addition of diethylzinc to cyclic enones catalyzed by Cu(I)-chiral sulfonamide-thiophosphoramide ligands and lithium salts ligand".Adv. Synth. Catal. 347.4(2005):535-540. |
入库方式: OAI收割
来源:上海有机化学研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。